Health
Athenex’s NDA for Breast Cancer Drug Gets Priority Review
Athenex, Inc. ATNX announced that the FDA has accepted the new drug application (NDA) for its pipeline candidate oral paclitaxel and encequidar (Oral Paclitaxel). The company is seeking an approval for the candidate to treat ... [Read]
Biotechnology
FibroGen to Present at Upcoming Investor Conferences
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following virtual healthcare conferences: Citigroup 15th Annual BioPharma ... [Read]
Biotechnology
Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020
CAMBRIDGE, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to ... [Read]
Biotechnology
BioMarin Down on CRL From FDA for Hemophilia A Candidate
BioMarin Pharmaceutical Inc. BMRN announced that the FDA has issued a complete response letter (CRL) to its biologics license application (BLA) for Roctavian (valoctocogene roxaparvovec/valrox), an investigational gene therapy, developed for treating patients with severe hemophilia ... [Read]
Biotechnology
BioMarin’s MAA for Dwarfism Candidate Gets EMA Validation
BioMarin Pharmaceutical Inc. BMRN announced that the European Medicines Agency (EMA) has accepted for review its marketing authorization application (MAA) for vosoritide. The company is seeking an approval for vosoritide, an investigational, once daily injection analog ... [Read]
Health
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, July 31, 2020 /PRNewswire/ — Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and ... [Read]
Biotechnology
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
— Company Reports Second Quarter Revenues of $247.5 Million, GAAP Net Loss per Share of $0.19 and Diluted Non-GAAP Earnings per Share of $0.06 — — ARISTADA® Net Sales Increased 21% Year-Over-Year to $58.8 Million — ... [Read]
Health
New Diagnostic Devices Help the Healthcare System Rally in Face of Severe Pressure
FinancialBuzz.com News Commentary New York, NY (7/23/2020) – The healthcare industry has made significant progress when it comes to efficiency and scope in the last several years, yet many complex issues remain unsolved. These issues ... [Read]
Biotechnology
Bio-Techne Announces Commercial Release Of New Assay For Detecting ASOs, miRNAs, And siRNAs In Tissue
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS, July 20, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with ... [Read]
Biotechnology
Best Biotech Stocks to Consider on April 27
The coronavirus pandemic has resulted in a major crisis in the markets over the past weeks, and many stocks across a range of sectors have recorded substantial declines during this period. However, one of the ... [Read]